P380: EX VIVO IMMUNE ACTIVATION WITH THE MACROPHAGE‐TARGETING IMMUNOTHERAPY, ANTI‐CLEVER‐1 ANTIBODY BEXMARILIMAB, IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME

Saved in:
Bibliographic Details
Published in:HemaSphere 2022-06, Vol.6, p.280-281
Main Authors: Aakko, S., Ylitalo, A., Kuusanmäki, H., Björkman, M., Mandelin, J., Jalkanen, J., Fjällskog, M.‐L., Heckman, C., Hollmén, M., Kontro, M.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000844408.27334.5c